| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |